Michael Becka

6.8k citations
51 papers · 5.4k · 5 hit papers · h-index 25

Impact in

    • Venous Thromboembolism Diagnosis and Management
    • Atrial Fibrillation Management and Outcomes
    • Cardiac Arrhythmias and Treatments
    • Antiplatelet Therapy and Cardiovascular Diseases
    • Cardiac electrophysiology and arrhythmias
    • Acute Myocardial Infarction Research

Papers in

Michael Becka

51 papers receiving 5.2k citations

Michael Becka's Hit Papers

Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban 2013 · 447 citations
4470+7+14Years since publication250500750

Peers

Michael Becka
Comparison fields: 5 of 111
  • Internal Medicine 2.2k
  • Cardiology and Cardiovascular Medicine 3.2k
  • Hepatology 450
  • Hematology 507
  • Pharmacology 239
Replace Dagmar Kubitza with:
Dagmar Kubitza Germany
Wolfgang Mueck Germany
John F. Paolini United States
Gerhard Nehmiz Germany
John Fanikos United States
Frank LaCreta United States
Joanne van Ryn Germany
Sylvia Haas Germany
Minggao Shi United States
Charles Frost United States
Michael Becka relative to Dagmar Kubitza Germany Dagmar Kubitza's profile →
Citations per field
00.5×6.6×
Dagmar Kubitza · 1×
Citations per year

Countries citing papers authored by Michael Becka

Since Specialization
Citations

This map shows the geographic impact of Michael Becka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Becka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Becka more than expected).

Fields of papers citing papers by Michael Becka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Becka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Becka. The network helps show where Michael Becka may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Becka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Becka Line = papers co-authored together Michael Becka links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Serum markers detect the presence of liver fibrosis: A cohort study
Hit paper breakdown →
2004879
2
Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor
Hit paper breakdown →
2005526
3
Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939—an oral, direct Factor Xa inhibitor—after multiple dosing in healthy male subjects
Hit paper breakdown →
2005524
4
Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban
Hit paper breakdown →
2013447
5 2010345
6
Co‐administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects
Hit paper breakdown →
2013324
7 2007277
8 2008220
9 2006206
10 2013167
11 2013162
12 2006151
13 2007143
14 2006132
15 2007121
16 201394
17 200671
18 200563
19 200155
20 200846

About Michael Becka

Michael Becka is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine, Hematology, Pharmacology and Nutrition and Dietetics, having authored 51 papers that have together received 5.4k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (20 papers), Venous Thromboembolism Diagnosis and Management (7 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers), Vitamin K Research Studies (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Cardiac Arrhythmias and Treatments (3 papers), Mast cells and histamine (3 papers) and Hormonal and reproductive studies (2 papers). The work is most often cited by research in Internal Medicine (2.2k citations), Cardiology and Cardiovascular Medicine (3.2k citations), Hepatology (450 citations), Hematology (507 citations) and Pharmacology (239 citations). Michael Becka has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Dagmar Kubitza, Wolfgang Mueck, Michael Zuehlsdorf, Barbara Voith, Georg Wensing, Jan Stampfuss, Angelika Roth, Michael Voelker, William Rosenberg and Alastair D. Burt. Their work appears in journals such as British Journal of Clinical Pharmacology, Blood, The Journal of Clinical Pharmacology, European Respiratory Journal and Atherosclerosis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact